Volution of Pulmonary Artery Dimensions in Tetralogy of Fallot
Key facts
- Where
- Strasbourg, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 0 and 18 years old?
Source: NCT07864129, who can take part
Where in France
- Service de pédiatrie 1 - CHU de Strasbourg - FranceStrasbourg, FranceContact: Laurent Bonnemains, MD, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Strasbourg, France
- Trial code
- NCT07864129
- Record updated
- 7 October 2026
- Original description
Tetralogy of Fallot is the most common cyanotic congenital heart disease. Management strategies vary between primary repair and staged approaches including palliative surgery. The development of pulmonary arteries is a key determinant in surgical decision-making.Read full original descriptionShow less
Tetralogy of Fallot is the most common cyanotic congenital heart disease. Management strategies vary between primary repair and staged approaches including palliative surgery. The development of pulmonary arteries is a key determinant in surgical decision-making.
This multicenter retrospective observational study aims to evaluate the evolution of pulmonary artery dimensions using the Nakata index at key stages of patient management (birth, palliative surgery, and complete repair). The goal is to assess its predictive value in optimizing surgical strategy and improving outcomes in patients with Tetralogy of Fallot or pulmonary atresia with ventricular septal defect.
Inclusion: Patients aged from birth to less than 18 years; Patients operated at Strasbourg or Bordeaux University Hospitals between 01/01/2010 and 31/12/2024; Patient (or legal guardians) not opposing the reuse of medical data for research purposes.
Exclusion: Absence of subvalvular obstruction and absence of muscular resection; Patient expressing opposition to participation in the study; Parents/legal guardians or minor opposing data reuse; Specific clinical forms (VDDI).